Middle East and Africa Nasal Spray Market - Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025
Middle East & Africa nasal spray market is expected with healthy CAGR of 5.0% in the forecast period of 2018 to 2025. The new market report contains data for the historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Market Segmentation:
By Product Type (Decongestion Nasal Spray, Steroid Nasal Spray, Salt Water Solution/ Saline Nasal Spray, Others), Container Design (Pressurized Canisters, Pump Bottles), Dosage Form (Unit/Single Dose, Bi Dose, Multi Dose), Prescription Mode (Over the Counter, Prescription Based), Therapeutic Class (Antihistamine, Nasal Steroids, Mast Cell Inhibitor, Anticholinergic), Application (Nasal Congestion, Allergic and Non-Allergic Rhinitis, Central Nervous System Disorders, Vaccination, Others), End User (Home Care Settings, Hospitals, Clinics, Community Health Care), Country (South Africa, Egypt, Saudi Arabia, United Arab Emirates, Israel, Rest of Middle East and Africa)
Major growing sectors under the market segmentation are as follows:
Market Segmentation:
By Product Type (Decongestion Nasal Spray, Steroid Nasal Spray, Salt Water Solution/ Saline Nasal Spray, Others), Container Design (Pressurized Canisters, Pump Bottles), Dosage Form (Unit/Single Dose, Bi Dose, Multi Dose), Prescription Mode (Over the Counter, Prescription Based), Therapeutic Class (Antihistamine, Nasal Steroids, Mast Cell Inhibitor, Anticholinergic), Application (Nasal Congestion, Allergic and Non-Allergic Rhinitis, Central Nervous System Disorders, Vaccination, Others), End User (Home Care Settings, Hospitals, Clinics, Community Health Care), Country (South Africa, Egypt, Saudi Arabia, United Arab Emirates, Israel, Rest of Middle East and Africa)
Major growing sectors under the market segmentation are as follows:
- In product type, decongestion nasal spray segment is expected to dominate the global nasal spray market due to the rising problems associated with the decongestion of conditions such as colds & flu, hay fever, allergic reactions and sinusitis are helping the segment to grow in the forecast period of 2018 to 2025.
- In therapeutic class, antihistamine segment is expected to dominate the market due to rising antihistamine usage amongst population for different diseases such as congestion, runny nose, sneezing, itching, nasal swelling and different products availability by the companies is expected to dominate the market, whereas nasal steroids are available for both prescription and over the counter usage, and fast effective results are the major growth factors of the market.
- In container design, pump bottles segment is expected to dominate the market due to the user friendly and wide offering of the over the counter products by the companies and it is expected to fuel the growth of pump bottles market in the forecast period. However, new advancement associated with the pressurized canisters.
- In doses form, multi does segment is expected to dominate the market due to the wide availability in different dose volumes and user friendly attributes it is expected to drive the market of unit/single dose in the forecast period.
- In prescription segment, prescription based segment is expected to dominate the market due to the rising chances of seasonal associated nasal problems and also for the various diseases such as pulmonary, dental anesthesia and others which leads the growth of prescription based segment is expected to fuel in the forecast period of 2018 to 2025.
- In application segment, nasal congestion segment is expected to dominate the market due to the rising cases of nasal congestion diseases such as runny nose, sinus pain, mucus buildup and also availability of the over the counter products, nasal congestion segment is expected to dominate market. However, allergic and non-allergic rhinitis is the fastest growing segment among all because of the rising problems amongst the population such as antihistamines, nasal corticosteroids, hay fever and other, also seasonal imbalance is one of the reasons in raising the allergic and non-allergic rhinitis segment to grow in the forecast period with the highest CAGR.
- ADAPT Pharma, Inc.
- Sandoz International GmbH
- INNOVUS PHARMACEUTICALS, INC.
- Cipla Inc.
- Aurena
- J Pharmaceuticals
- Bayer AG
- St. Renatus
- ARIUS FORMULATIONS PVT LTD
- Ultratech India Limited
- GlaxoSmithKline plc
- Egalet Corporation
- LEEFORD HEALTHCARE LTD
- Aishwarya Group
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NASAL SPRAY MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 SECONDARY SOURCES
2.8 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 IMPROVING PATIENT COMPLIANCE AND ACCEPTABILITY
3.1.2 EFFECTIVENESS OVER OTHER FORMS OF DRUG DELIVERY
3.1.3 INCREASE IN INFECTION & ALLERGIC CASES
3.2 RESTRAINTS
3.2.1 PRODUCT RECALLS
3.3 OPPORTUNITIES
3.3.1 NEW RISING DEMAND FOR SELF ADMINISTRATIVE DRUG DELIVERY
3.3.2 EXPANDING THERAPEUTIC APPLICATIONS FOR NASAL SPRAYS
3.4 CHALLENGES
3.4.1 REGULATORY HURDLES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY PRODUCT TYPE
6.1 OVERVIEW
6.2 DECONGESTION NASAL SPRAY
6.3 SALT WATER SOLUTION/ SALINE NASAL SPRAY
6.4 STEROID NASAL SPRAY
6.5 OTHERS
7 MIDDLE EAST AND AFRICA N ASAL SPRAY MARKET, BY CONTAINER DESIGN
7.1 OVERVIEW
7.2 PRESSURIZED CANISTERS
7.3 PUMP BOTTLES
8 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY DOSAGE FORM
8.1 OVERVIEW
8.2 UNIT/SINGLE DOSE
8.3 BI DOSE
8.4 MULTI DOSE
9 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS
9.1 OVERVIEW
9.2 ANTIHISTAMINE
9.3 NASAL STEROIDS
9.4 MAST CELL INHIBITOR
9.5 ANTICHOLINERGIC
10 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 ALLERGIC AND NON-ALLERGIC RHINITIS
10.3 NASAL CONGESTION
10.4 CENTRAL NERVOUS SYSTEM DISORDERS
10.5 VACCINATION
10.6 OTHERS
11 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY PRESCRIPTION MODE
11.1 OVERVIEW
11.2 PRESCRIPTION BASED
11.3 OVER THE COUNTER
12 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS
12.3 CLINICS
12.4 HOME CARE SETTINGS
12.5 COMMUNITY HEALTH CARE
13 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY GEOGRAPHY
13.1 MIDDLE EAST AND AFRICA
13.1.1 GROWING PREFERENCES FOR DRUG ADMINISTRATION THROUGH INTRA NASAL ROUTE
13.1.2 SOUTH AFRICA
13.1.3 EGYPT
13.1.4 SAUDI ARABIA
13.1.5 UNITED ARAB EMIRATES
13.1.6 ISRAEL
13.1.7 REST OF MIDDLE EAST & AFRICA
14 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
15 COMPANY PROFILE
15.1 PFIZER INC.
15.1.1 COMPANY OVERVIEW
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 CIPLA INC.
15.2.1 COMPANY OVERVIEW
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENTS
15.3 BAYER AG
15.3.1 COMPANY OVERVIEW
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENTS
15.4 INNOVUS PHARMACEUTICALS, INC.
15.4.1 COMPANY OVERVIEW
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENTS
15.5 GLAXOSMITHKLINE PLC.
15.5.1 COMPANY OVERVIEW
15.5.2 REVENUE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT DEVELOPMENTS
15.6 ADAPT PHARMA, INC.
15.6.1 COMPANY OVERVIEW
15.6.2 GEOGRAPHIC PRESENCE
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENTS
15.7 AISHWARYA GROUP
15.7.1 COMPANY OVERVIEW
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENTS
15.8 ALLERGAN
15.8.1 COMPANY OVERVIEW
15.8.2 REVENUE ANALYSIS
15.8.3 PRODUCT PORTFOLIO
15.8.4 RECENT DEVELOPMENTS
15.9 ARIUS FORMULATIONS PVT LTD
15.9.1 COMPANY OVERVIEW
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENTS
15.10 AURENA
15.10.1 COMPANY OVERVIEW
15.10.2 GEOGRAPHIC PRESENCE
15.10.3 PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENTS
15.11 CATALENT, INC
15.11.1 COMPANY OVERVIEW
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 RECENT DEVELOPMENTS
15.12 EGALET CORPORATION
15.12.1 COMPANY OVERVIEW
15.12.2 REVENUE ANALYSIS
15.12.3 PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENTS
15.13 J PHARMACEUTICALS
15.13.1 COMPANY OVERVIEW
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENTS
15.14 LEEFORD HEALTHCARE LTD
15.14.1 COMPANY OVERVIEW
15.14.2 GEOGRAPHIC PRESENCE
15.14.3 PRODUCT PORTFOLIO
15.14.4 RECENT DEVELOPMENTS
15.15 MYLAN N.V.
15.15.1 REVENUE ANALYSIS
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENTS
15.16 SANDOZ INTERNATIONAL GMBH
15.16.1 COMPANY OVERVIEW
15.16.2 GEOGRAPHIC PRESENCE
15.16.3 PRODUCT PORTFOLIO
15.16.4 RECENT DEVELOPMENTS
15.17 ST. RENATUS
15.17.1 COMPANY OVERVIEW
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENTS
15.18 TEVA PHARMACEUTICAL INDUSTRIES LTD.
15.18.1 COMPANY OVERVIEW
15.18.2 REVENUE ANALYSIS
15.18.3 PRODUCT PORTFOLIO
15.18.4 RECENT DEVELOPMENTS
15.19 ULTRATECH INDIA LIMITED
15.19.1 COMPANY OVERVIEW
15.19.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENTS
16 RELATED REPORTS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NASAL SPRAY MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 SECONDARY SOURCES
2.8 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 IMPROVING PATIENT COMPLIANCE AND ACCEPTABILITY
3.1.2 EFFECTIVENESS OVER OTHER FORMS OF DRUG DELIVERY
3.1.3 INCREASE IN INFECTION & ALLERGIC CASES
3.2 RESTRAINTS
3.2.1 PRODUCT RECALLS
3.3 OPPORTUNITIES
3.3.1 NEW RISING DEMAND FOR SELF ADMINISTRATIVE DRUG DELIVERY
3.3.2 EXPANDING THERAPEUTIC APPLICATIONS FOR NASAL SPRAYS
3.4 CHALLENGES
3.4.1 REGULATORY HURDLES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY PRODUCT TYPE
6.1 OVERVIEW
6.2 DECONGESTION NASAL SPRAY
6.3 SALT WATER SOLUTION/ SALINE NASAL SPRAY
6.4 STEROID NASAL SPRAY
6.5 OTHERS
7 MIDDLE EAST AND AFRICA N ASAL SPRAY MARKET, BY CONTAINER DESIGN
7.1 OVERVIEW
7.2 PRESSURIZED CANISTERS
7.3 PUMP BOTTLES
8 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY DOSAGE FORM
8.1 OVERVIEW
8.2 UNIT/SINGLE DOSE
8.3 BI DOSE
8.4 MULTI DOSE
9 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS
9.1 OVERVIEW
9.2 ANTIHISTAMINE
9.3 NASAL STEROIDS
9.4 MAST CELL INHIBITOR
9.5 ANTICHOLINERGIC
10 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 ALLERGIC AND NON-ALLERGIC RHINITIS
10.3 NASAL CONGESTION
10.4 CENTRAL NERVOUS SYSTEM DISORDERS
10.5 VACCINATION
10.6 OTHERS
11 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY PRESCRIPTION MODE
11.1 OVERVIEW
11.2 PRESCRIPTION BASED
11.3 OVER THE COUNTER
12 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS
12.3 CLINICS
12.4 HOME CARE SETTINGS
12.5 COMMUNITY HEALTH CARE
13 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY GEOGRAPHY
13.1 MIDDLE EAST AND AFRICA
13.1.1 GROWING PREFERENCES FOR DRUG ADMINISTRATION THROUGH INTRA NASAL ROUTE
13.1.2 SOUTH AFRICA
13.1.3 EGYPT
13.1.4 SAUDI ARABIA
13.1.5 UNITED ARAB EMIRATES
13.1.6 ISRAEL
13.1.7 REST OF MIDDLE EAST & AFRICA
14 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
15 COMPANY PROFILE
15.1 PFIZER INC.
15.1.1 COMPANY OVERVIEW
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 CIPLA INC.
15.2.1 COMPANY OVERVIEW
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENTS
15.3 BAYER AG
15.3.1 COMPANY OVERVIEW
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENTS
15.4 INNOVUS PHARMACEUTICALS, INC.
15.4.1 COMPANY OVERVIEW
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENTS
15.5 GLAXOSMITHKLINE PLC.
15.5.1 COMPANY OVERVIEW
15.5.2 REVENUE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT DEVELOPMENTS
15.6 ADAPT PHARMA, INC.
15.6.1 COMPANY OVERVIEW
15.6.2 GEOGRAPHIC PRESENCE
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENTS
15.7 AISHWARYA GROUP
15.7.1 COMPANY OVERVIEW
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENTS
15.8 ALLERGAN
15.8.1 COMPANY OVERVIEW
15.8.2 REVENUE ANALYSIS
15.8.3 PRODUCT PORTFOLIO
15.8.4 RECENT DEVELOPMENTS
15.9 ARIUS FORMULATIONS PVT LTD
15.9.1 COMPANY OVERVIEW
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENTS
15.10 AURENA
15.10.1 COMPANY OVERVIEW
15.10.2 GEOGRAPHIC PRESENCE
15.10.3 PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENTS
15.11 CATALENT, INC
15.11.1 COMPANY OVERVIEW
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 RECENT DEVELOPMENTS
15.12 EGALET CORPORATION
15.12.1 COMPANY OVERVIEW
15.12.2 REVENUE ANALYSIS
15.12.3 PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENTS
15.13 J PHARMACEUTICALS
15.13.1 COMPANY OVERVIEW
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENTS
15.14 LEEFORD HEALTHCARE LTD
15.14.1 COMPANY OVERVIEW
15.14.2 GEOGRAPHIC PRESENCE
15.14.3 PRODUCT PORTFOLIO
15.14.4 RECENT DEVELOPMENTS
15.15 MYLAN N.V.
15.15.1 REVENUE ANALYSIS
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENTS
15.16 SANDOZ INTERNATIONAL GMBH
15.16.1 COMPANY OVERVIEW
15.16.2 GEOGRAPHIC PRESENCE
15.16.3 PRODUCT PORTFOLIO
15.16.4 RECENT DEVELOPMENTS
15.17 ST. RENATUS
15.17.1 COMPANY OVERVIEW
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENTS
15.18 TEVA PHARMACEUTICAL INDUSTRIES LTD.
15.18.1 COMPANY OVERVIEW
15.18.2 REVENUE ANALYSIS
15.18.3 PRODUCT PORTFOLIO
15.18.4 RECENT DEVELOPMENTS
15.19 ULTRATECH INDIA LIMITED
15.19.1 COMPANY OVERVIEW
15.19.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENTS
16 RELATED REPORTS
LIST OF TABLES
Table 1 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016 -2025, (USD MILLION)
Table 2 MIDDLE EAST AND AFRICA DECONGESTION NASAL SPRAY IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 3 MIDDLE EAST AND AFRICA SALT WATER SOLUTION/ SALINE NASAL SPRAY IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 4 MIDDLE EAST AND AFRICA STEROID NASAL SPRAY IN NASAL SPRAY MARKET, BY REGION, USD MILLION (2016 -2025)
Table 5 MIDDLE EAST AND AFRICA OTHERS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 6 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016 -2025, (USD MILLION)
Table 7 MIDDLE EAST AND AFRICA PRESSURIZED CANISTERS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 8 MIDDLE EAST AND AFRICA PUMP BOTTLES IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 9 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY DOSAGE FORM, 2016 -2025, (USD MILLION)
Table 10 MIDDLE EAST AND AFRICA UNIT/SINGLE DOSE IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 11 MIDDLE EAST AND AFRICA BI DOSE IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 12 MIDDLE EAST AND AFRICA MULTI-DOSE IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 13 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016 -2025, (USD MILLION)
Table 14 MIDDLE EAST AND AFRICA ANTIHISTAMINE IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 15 MIDDLE EAST AND AFRICA NASAL STEROID IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 16 MIDDLE EAST AND AFRICA MAST CELL INHIBITOR IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 17 MIDDLE EAST AND AFRICA ANTICHOLINERGIC IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 18 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY APPLICATION, 2016 -2025, (USD MILLION)
Table 19 MIDDLE EAST AND AFRICA ALLERGIC AND NON-ALLERGIC RHINITIS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 20 MIDDLE EAST AND AFRICA NASAL CONGESTION RHINITIS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 21 MIDDLE EAST AND AFRICA CENTRAL NERVOUS SYSTEM DISORDERS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 22 MIDDLE EAST AND AFRICA VACCINATION IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 23 MIDDLE EAST AND AFRICA OTHERS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 24 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016 -2025, (USD MILLION)
Table 25 MIDDLE EAST AND AFRICA PRESCRIPTION BASED IN NASAL SPRAY MARKET, BY REGION, USD MILLION (2016 -2025)
Table 26 MIDDLE EAST AND AFRICA OVER THE COUNTER BASED IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 27 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY END USER, 2016 -2025, (USD MILLION)
Table 28 MIDDLE EAST AND AFRICA HOSPITALS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 29 MIDDLE EAST AND AFRICA CLINICS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 30 MIDDLE EAST AND AFRICA HOME CARE SETTINGS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 31 MIDDLE EAST AND AFRICA COMMUNITY HEALTH CARE IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 32 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY COUNTRY, 2016-2025, (USD MILLION)
Table 33 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
Table 34 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION)
Table 35 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION)
Table 36 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION)
Table 37 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION)
Table 38 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION)
Table 39 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION)
Table 40 SOUTH AFRICA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
Table 41 SOUTH AFRICA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION)
Table 42 SOUTH AFRICA NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION)
Table 43 SOUTH AFRICA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION)
Table 44 SOUTH AFRICA NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION)
Table 45 SOUTH AFRICA NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION)
Table 46 SOUTH AFRICA NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION)
Table 47 REST OF MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
Table 1 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016 -2025, (USD MILLION)
Table 2 MIDDLE EAST AND AFRICA DECONGESTION NASAL SPRAY IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 3 MIDDLE EAST AND AFRICA SALT WATER SOLUTION/ SALINE NASAL SPRAY IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 4 MIDDLE EAST AND AFRICA STEROID NASAL SPRAY IN NASAL SPRAY MARKET, BY REGION, USD MILLION (2016 -2025)
Table 5 MIDDLE EAST AND AFRICA OTHERS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 6 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016 -2025, (USD MILLION)
Table 7 MIDDLE EAST AND AFRICA PRESSURIZED CANISTERS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 8 MIDDLE EAST AND AFRICA PUMP BOTTLES IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 9 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY DOSAGE FORM, 2016 -2025, (USD MILLION)
Table 10 MIDDLE EAST AND AFRICA UNIT/SINGLE DOSE IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 11 MIDDLE EAST AND AFRICA BI DOSE IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 12 MIDDLE EAST AND AFRICA MULTI-DOSE IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 13 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016 -2025, (USD MILLION)
Table 14 MIDDLE EAST AND AFRICA ANTIHISTAMINE IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 15 MIDDLE EAST AND AFRICA NASAL STEROID IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 16 MIDDLE EAST AND AFRICA MAST CELL INHIBITOR IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 17 MIDDLE EAST AND AFRICA ANTICHOLINERGIC IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 18 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY APPLICATION, 2016 -2025, (USD MILLION)
Table 19 MIDDLE EAST AND AFRICA ALLERGIC AND NON-ALLERGIC RHINITIS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 20 MIDDLE EAST AND AFRICA NASAL CONGESTION RHINITIS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 21 MIDDLE EAST AND AFRICA CENTRAL NERVOUS SYSTEM DISORDERS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 22 MIDDLE EAST AND AFRICA VACCINATION IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 23 MIDDLE EAST AND AFRICA OTHERS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 24 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016 -2025, (USD MILLION)
Table 25 MIDDLE EAST AND AFRICA PRESCRIPTION BASED IN NASAL SPRAY MARKET, BY REGION, USD MILLION (2016 -2025)
Table 26 MIDDLE EAST AND AFRICA OVER THE COUNTER BASED IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 27 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET, BY END USER, 2016 -2025, (USD MILLION)
Table 28 MIDDLE EAST AND AFRICA HOSPITALS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 29 MIDDLE EAST AND AFRICA CLINICS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 30 MIDDLE EAST AND AFRICA HOME CARE SETTINGS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 31 MIDDLE EAST AND AFRICA COMMUNITY HEALTH CARE IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION)
Table 32 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY COUNTRY, 2016-2025, (USD MILLION)
Table 33 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
Table 34 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION)
Table 35 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION)
Table 36 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION)
Table 37 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION)
Table 38 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION)
Table 39 MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION)
Table 40 SOUTH AFRICA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
Table 41 SOUTH AFRICA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION)
Table 42 SOUTH AFRICA NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION)
Table 43 SOUTH AFRICA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION)
Table 44 SOUTH AFRICA NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION)
Table 45 SOUTH AFRICA NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION)
Table 46 SOUTH AFRICA NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION)
Table 47 REST OF MIDDLE EAST & AFRICA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION)
LIST OF FIGURES
Figure 1 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: SEGMENTATION
Figure 2 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: DATA TRIANGULATION
Figure 3 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: RESEARCH SNAPSHOT
Figure 4 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET:BOTTOM UP APPROACH
Figure 5 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET:TOP DOWN APPROACH
Figure 6 MIDDLE EAST AND AFRICANASAL SPRAY MARKET: INTERVIEW DEMOGRAPHICS
Figure 7 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST AND AFRICA NASAL SPRAY MARKET
Figure 8 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: SEGMENTATION
Figure 9 IMPROVING PATIENT COMPLIANCE AND ACCEPTIBILITY AND EFFECTIVENESS OVER OTHER FORMS OF DRUG DELIVERY ARE EXPECTED TO DRIVE THE MARKET FOR NASAL SPRAY IN THE FORECAST PERIOD 2018 TO 2025
Figure 10 DECONGESTION NASAL SPRAY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NASAL SPRAY MARKET IN 2018 & 2025
Figure 11 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: BY PRODUCT TYPE, 2017
Figure 12 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: BY CONTAINER DESIGN, 2017
Figure 13 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: BY DOSAGE FORM, 2017
Figure 14 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: BY THERAPEUTIC CLASS, 2017
Figure 15 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: BY APPLICATION, 2017
Figure 16 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: BY PRESCRIPTION MODE, 2017
Figure 17 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: BY END USER, 2017
Figure 18 MIDDLE EAST & AFRICA NASAL SPRAY MARKET SNAPSHOT (2017)
Figure 19 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY COUNTRY (2017)
Figure 20 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY COUNTRY (2018 & 2025)
Figure 21 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY COUNTRY (2017 & 2025)
Figure 22 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY PRODUCT TYPE (2018 - 2025)
Figure 23 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: COMPANY SHARE 2017 (%)
Figure 1 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: SEGMENTATION
Figure 2 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: DATA TRIANGULATION
Figure 3 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: RESEARCH SNAPSHOT
Figure 4 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET:BOTTOM UP APPROACH
Figure 5 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET:TOP DOWN APPROACH
Figure 6 MIDDLE EAST AND AFRICANASAL SPRAY MARKET: INTERVIEW DEMOGRAPHICS
Figure 7 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST AND AFRICA NASAL SPRAY MARKET
Figure 8 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: SEGMENTATION
Figure 9 IMPROVING PATIENT COMPLIANCE AND ACCEPTIBILITY AND EFFECTIVENESS OVER OTHER FORMS OF DRUG DELIVERY ARE EXPECTED TO DRIVE THE MARKET FOR NASAL SPRAY IN THE FORECAST PERIOD 2018 TO 2025
Figure 10 DECONGESTION NASAL SPRAY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NASAL SPRAY MARKET IN 2018 & 2025
Figure 11 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: BY PRODUCT TYPE, 2017
Figure 12 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: BY CONTAINER DESIGN, 2017
Figure 13 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: BY DOSAGE FORM, 2017
Figure 14 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: BY THERAPEUTIC CLASS, 2017
Figure 15 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: BY APPLICATION, 2017
Figure 16 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: BY PRESCRIPTION MODE, 2017
Figure 17 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: BY END USER, 2017
Figure 18 MIDDLE EAST & AFRICA NASAL SPRAY MARKET SNAPSHOT (2017)
Figure 19 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY COUNTRY (2017)
Figure 20 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY COUNTRY (2018 & 2025)
Figure 21 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY COUNTRY (2017 & 2025)
Figure 22 MIDDLE EAST & AFRICA NASAL SPRAY MARKET: BY PRODUCT TYPE (2018 - 2025)
Figure 23 MIDDLE EAST AND AFRICA NASAL SPRAY MARKET: COMPANY SHARE 2017 (%)
